Heath, H., Yoo, J. Y., Akter, S., Jain, A., Sharma, V., McGee, H., Soliman, A., Mahmoud, A. M., Matthews, A. K., Winn, R. A., Madak-Erdogan, Z., & Kim, S. J. (2024). The Effect of Exposure to Neighborhood Violence on Glucocorticoid Receptor Signaling in Lung Tumors. Cancer Research Communications, 4(7), 1643–1654. https://doi.org/10.1158/2767-9764.crc-24-0032

Rustgi, N., Wu, S., Samec, T., Walker, P., Xiu, J., Lou, E., Goel, S., Saeed, A., & Moy, R. H. (2024). Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer. Cancer Research Communications, 4(6), 1399–1409. https://doi.org/10.1158/2767-9764.crc-23-0496

Yarchoan, M., Powderly, J. D., Bastos, B. R., Karasic, T. B., Crysler, O. V., Munster, P. N., McKean, M. A., Emens, L. A., Saenger, Y. M., Ged, Y., Stagg, R., Smith, S., Whiting, C. C., Moon, A., Prasit, P., Jenkins, Y., Standifer, N., Dubensky, T. W., Whiting, S. H., & Ulahannan, S. V. (2024). First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors. Cancer Research Communications, 4(4), 1100–1110. https://doi.org/10.1158/2767-9764.crc-24-0082

Abou-Alfa, G. K., Geyer, S. M., Nixon, A. B., Innocenti, F., Shi, Q., Kumthekar, P., Jacobson, S., El Dika, I., Yaqubie, A., Lopez, J., Huang, B., Tang, Y.-W., Wen, Y., Schwartz, L. H., El-Khoueiry, A. B., Knox, J. J., Rajdev, L., Bertagnolli, M. M., Meyerhardt, J. A., … Venook, A. P. (2024). CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer Research Communications, 4(3), 682–690. https://doi.org/10.1158/2767-9764.crc-22-0516

Banerjee, D., Boboila, S., Okochi, S., Angelastro, J. M., Kadenhe-Chiweshe, A. V., Lopez, G., Califano, A., Connolly, E. P., Greene, L. A., & Yamashiro, D. J. (2023). Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance. Cancer Research Communications, 3(12), 2518–2530. https://doi.org/10.1158/2767-9764.crc-23-0154

Ambrosini, G., Natale, C. A., Musi, E., Garyantes, T., & Schwartz, G. K. (2023). The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells. Cancer Research Communications, 3(4), 540–547. https://doi.org/10.1158/2767-9764.crc-22-0399

Dermawan, J. K. T., Nafa, K., Mohanty, A., Xu, Y., Rijo, I., Casanova, J., Villafania, L., Benhamida, J., Kelly, C. M., Tap, W. D., Boland, P. J., Fabbri, N., Healey, J. H., Ladanyi, M., Lu, C., & Hameed, M. (2023). Distinct IDH1/2-associated Methylation Profile and Enrichment ofTP53andTERTMutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma. Cancer Research Communications, 3(3), 431–443. https://doi.org/10.1158/2767-9764.crc-22-0397

Saeki, K., Qiu, W., Friedman, R. A., Pan, S., Lu, J., Ichimiya, S., Chio, I. I. C., Shawber, C. J., Kitajewski, J., Hu, J., & Su, G. H. (2022). Inactivation ofNotch4Attenuated Pancreatic Tumorigenesis in Mice. Cancer Research Communications, 2(12), 1601–1616. https://doi.org/10.1158/2767-9764.crc-22-0106

Baik, J. E., Li, L., Shah, M. A., Freedberg, D. E., Jin, Z., Wang, T. C., & Han, Y. W. (2022). Circulating IgA Antibodies AgainstFusobacterium nucleatumAmyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia. Cancer Research Communications, 2(11), 1497–1503. https://doi.org/10.1158/2767-9764.crc-22-0248

Gong, Y.-Y., Shao, H., Li, Y., Brafford, P., Stine, Z. E., Sun, J., Felsher, D. W., Orange, J. S., Albelda, S. M., & Dang, C. V. (2022). Na+/H+-exchanger 1 Enhances Antitumor Activity of Engineered NK-92 Natural Killer Cells. Cancer Research Communications, 2(8), 842–856. https://doi.org/10.1158/2767-9764.crc-22-0270